Vioxx: The Downfall of a Drug Merck removed one of the world's best-selling painkillers from the market in 2004 after a study showed Vioxx caused an increased risk of serious cardiovascular events, such as stroke and heart attack. Now, Merck agrees to pay $4.85B to end thousands of lawsuits.
thumbnail
Special Series

Vioxx: The Downfall of a Drug

Merck removed Vioxx from the market after a study showed it could cause heart attack and stroke.